Analysts’ Downgrades for March 16th (AMOD, BDRFF, BELFB, EQR, HAIN, IMCR, INCY, IXHL, OEC, ONC)

Analysts’ downgrades for Monday, March 16th:

Alpha Modus (NASDAQ:AMOD) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating.

Bel Fuse (NASDAQ:BELFB) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Equity Residential (NYSE:EQR) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

The Hain Celestial Group (NASDAQ:HAIN) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. They currently have $0.50 price target on the stock, down from their previous price target of $1.50.

Immunocore (NASDAQ:IMCR) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. They currently have $33.00 target price on the stock, down from their previous target price of $48.00.

Incyte (NASDAQ:INCY) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. Jefferies Financial Group Inc. currently has $94.00 target price on the stock, down from their previous target price of $120.00.

Incannex Healthcare (NASDAQ:IXHL) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Orion (NYSE:OEC) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

BeOne Medicines (NASDAQ:ONC) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. The firm currently has $290.00 target price on the stock, down from their previous target price of $420.00.

Chicago Atlantic Real Estate Finance (NASDAQ:REFI) was downgraded by analysts at Oppenheimer Holdings, Inc. from an outperform rating to a market perform rating.

Summit Therapeutics (NASDAQ:SMMT) was downgraded by analysts at Jefferies Financial Group Inc. from a buy rating to a hold rating. They currently have $15.00 target price on the stock, down from their previous target price of $42.00.

Weatherford International (NASDAQ:WFRD) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.